We describe a new rapid, sensitive high-performance liquidchromatographic (HPLC) method for determining ferrochelatase (EC 4.99.1.1) activity in lymphocytes. Zinc and mesoporphyrin are incubated aerobically with sonicated lymphocytes and the zinc mesoporphyrin formed is extracted with dimethyl sulfoxide-methanol-EDTA for quantification by HPLC. Incubation conditions, including the concentration of the palmitic acid activator, were optimized. The Michaelis constant (K) was 2.1 anol/L for mesoporphyrin, 22.2 imol/L for zinc. Determining ferrochelatase activity by using nonradioactive ferrous iron (4, 5) requires anaerobic conditions and lacks the sensitivity for measuring activity in fibroblasts or lymphocytes. Radiochemical methods with 59Fe2 as substrate provide much greater sensitivity (6, 7) but still require strictly anaerobic conditions to prevent the oxidation of ferrous iron. Several problems also arise in separating labeled heme from the free 59Fe2, especially because the heme may be unstable under the assay conditions used (5). Moreover, radiochemical methods may yield inconsistent results. For example, patients with variegate porphyria reportedly have either normal (8) or diminished (9) ferrochelatase activity in their fibroblasts.
FerrochelataseActivity in Human Lymphocytes
Determining ferrochelatase activity by using nonradioactive ferrous iron (4, 5) requires anaerobic conditions and lacks the sensitivity for measuring activity in fibroblasts or lymphocytes. Radiochemical methods with 59Fe2 as substrate provide much greater sensitivity (6, 7) but still require strictly anaerobic conditions to prevent the oxidation of ferrous iron. Several problems also arise in separating labeled heme from the free 59Fe2, especially because the heme may be unstable under the assay conditions used (5 fluorescence-based method has the sensitivity required for assay of the enzyme in lymphocytes, where activity is only 10% of that reported for rat liver as measured with use of the same substrates. We have optimized the incubation conditions and described the preparation and storage of the enzyme extract. We determined a reference interval for lymphocyte ferrochelatase activity and compared the enzyme activities in lymphocytes and neutrophils. Using our assay, we confirm that lymphocyte ferrochelatase activity is reduced in EHP.
Materials and Methods

Materials:
We using Ficoll-Paque (13). Contaminating erythrocytes were lysed in a solution containing, per liter, 155 mmol of NH4C1, 20 mmol of KHCO3, and 0.1 mmol of disodium ED'FA (14). We used differential staining with May-Grunwald-Giemsa stain to show that the resulting lymphocyte-monocyte fraction was 96% pure. Following common usage, this fraction is referred to as the "lymphocyte fraction." The cells were washed with 150 mmoJJL saline, then resuspended in 0.3 rnL of buffered glycerol-DTF at 4#{176}C. This solution improves the activity and stability of rat liver (15) and bovine liver (16) ferrochelatase. The lymphocyte enzyme preparation was made by somcating the cells at 4#{176}C for 20 s with the microprobe set at 30% of maximum power. Sonication for periods up to 3 x 20s did not increase the yield of enzyme. The enzyme preparation was stable for at least three days at 4#{176}C cr14 days at -20 #{176}C. We determined protein concentrations of the enzyme preparations by a trichloroacetic acidPonceau S method, using human serum albumin as standard (17) .
Neutrophils: Heparin blood (10 mL) was mixed with 2 mL of a 50 g/L solution of dextran (Mr 200 000-275 000) in isotonic saline and left to stand for 1 h. The dextran-plasma was centrifuged with Ficoll-Paque to obtain a neutrophil pellet (18). Contaminating erythrocytes were lysed as described for the lymphocytes, and the neutrophils were washed with isotonic saline. Differential staining (MayGrunwald-Giemsa stain) of films of the neutrophil fraction showed 2-3% contamination with lymphocytes. The neutrophil pellet was resuspended in 0.3 mL of buffered glycerol-DF at 4#{176}C and lysed by sonication as for the lymphocyte fraction.
Standard zinc rnesoporphyrin:
We prepared zinc mesoporphyrin by refiuxing mesoporphyrin and zinc acetate in chloroform for 10 mm as described by Li et al. (11) . A stock solution was prepared in DMSO, and its concentration was determined as follows. After diluting 10-fold with 2.7 mol/L HC1 we left it to stand for 10 mm, to allow complete demetallation, and then further diluted with water to give a final HC1 concentration of 0.1 mol/L. The absorbance was measured at 399 mn, and the concentration of mesoporphyrin was calculated as before. We prepared a series of zinc mesoporphyrin standards by diluting the stock in DMSOmethanol-EDTA to give concentrations of 50 to 500 nmoIJL. These were stable at 4#{176}C for at least seven days if kept in the dark. hjection (20 zL) into the HPLC unit gave fluorescence peak areas that were linearly related to concentration in the range 50-500 nmolJL. 
The fluorescence response for zinc mesoporphyrin was 160 times greater than that given by equimolar mesoporphynn.
The separation was performed on a 3.9 mm x 15 cm stainless-steel column (Waters, Milford, MA 01757) packed with 4-pm Novapak C18 silica. The flow rate was 1.5 mL/min. We prepared the mobile phase by adding 120 mL of amnionium acetate buffer (1 mol/L, pH 5.16) to 880 mL of methanol.
Assay blanks: Non-enzymic incorporation of zinc into mesoporphyrin was assessedby heat-inactivating an aliquot of each lymphocyte sonicate at 100 #{176}C for 10 mm. It averaged 6% of the enzymic formation (Table 1 ) and was independent of the protein concentration of the lymphocyte preparation. Each batch included a protein-free reagent blank, prepared by substituting buffered glycerol-DTF for the enzyme, which gave slightly lower zinc mesoporphyrin formation than the heat-inactivated blank (Table 1) and was used to monitor the non-enzymic reaction due to the reagents alone.
Enzyme activity: Figure 1 depicts HPLC traces given by injecting 20 pL of supernates from a heat-inactivated blank and a test sample. Zinc mesoporphyrin and mesoporphyrin were completely separated in 4 mm. The concentrations of zinc mesoporphyrin (nmolfL) in the tests and heated blanks were calculated from the HPLC peak areas of the standards. We subtracted the zinc mesoporphyrin concentration (nmol/L) of the heat-inactivated blank and expressed enzyme activity as zinc mesoporphn formed per hour per milligram of lymphocyte protein (nmol . h' . mg'). Enzyme activity was calculated as follows: Zn meso (test-blank) 20 1000 protein where "Zn meso" is the concentration of product in nniol -h1 L' and "protein" is the protein concentration of the lymphocyte enzyme preparation in g/L.
Results and Discussion
Enzyme substrates: Previous studies have shown that zinc (10) and cobalt (19) can be utilized as substrates with aerobic conditions. Taketani and Tokunaga (20) provided direct evidence that ferrochelatase can use zinc or cobalt as well as iron as a substrate by showing that an antibody to the enzyme inhibited chelation of all three metals.
Several dicarboxylic prophyrmns are substrates for ferrochelatase. Mesoporphyrin is the most active substrate for bovine liver and rat liver, followed by deuteroporphyrin and then protoporphyrin (20) . For nine normal-lymphocyte preparations we obtained a 6.4-fold greater activity with mesoporphyrin than with protoporphyrin. Mesoporphyrin is also more stable than protoporphyrin and was used as substrate in this study.
Non-enzymic reaction: Using iron and a variety of dicarboxylic prophyrins as substrates, several authors (21, 22) have described the non-enzymic formation of metalloporphyrins. They used Tris HC1 buffer and incubation conditions typical of ferrochelatase assays. The inclusion of detergent in the incubation buffer is essential in minimizing the non-enzymic blank. Triton X-100 and Nonidet-P40 proved to be fluorescent in our assay. However, Tween 20, a nonfluorescent detergent, has been widely used for ferrochelatase (6, 7), and we found a final concentration of 6 g/L to be optimum.
Ti-is HC1 buffer has been widely used for ferrochelatase determination (7, 19, 20) . However, when 200 mmolJL Tris HC1, pH 8.0, was used to prepare the incubation buffer, we observed a high value for the heat-inactivated blank-up to 15% of the total enzyme activity. Bloomer et al. (10) used zinc and protoporphyrin with Tris HC1 buffer containing 10 g of Tween 20 per liter and reported that non-enzymic product formation accounted for up to 10% of the total product formed. We tested a combined 40 mmol/L Bicine and 160 moIJL Ti-is buffer and found that it reduced the value for the heated blank to a mean of 6% of the total product formed (Table 1 ) and increased the specific activity by 10%.
Fatty acid activation:
Purified rat liver ferrochelatase contains fatty acids, and the addition of exogenous fatty acids increases enzyme activity by as much as 15-fold (15). In contrast, purified bovine-liver ferrochelatase contains neither fatty acids nor phospholipids, and its activity is enhanced by only 20% by added exogenous fatty acids or other lipids (16). Li et al. (11), using zinc and mesoporphyrin as substrates, reported that palmitic acid increased the activity of crude rat liver ferrochelatase. We have been unable to find any report describing fatty acid activation of ferrochelatase from human tissue. We found that the addition of palmitic acid gave a maximum of a seven-to eightfold enhancement of enzyme activity (Figure 2) .
Extraction of zinc mesoporphyrin: Zinc prophyrins are quantitatively demetallated by contact with strong acids and the reaction cannot be stopped with acidic protein denaturants (11). We have previously reported (23) that DM80 is an excellent extractant and solvent for erythrocyte zinc protoporphyrmn, which is tightly bound to hemoglobin. With the greater sensitivity allowed by fluorescence detection we found significant non-enzymic zinc incorporation continued after the addition of DM80-methanol before HPLC separation. We solvedthis problem by incorporating 270 mmol of EDTA per liter in the DMSO-methanol, which prevented further zinc incorporation.
The deproteinized samples are stable for at least 24 h in the dark at 4#{176}C, so that I{PLC separation can be delayed if necessary. EDTA did not dechelate any pre-formed zinc prophyrin complexes; for example, zinc prothporphyrin is stable in EDTA-anticoagulated blood samples for eight weeks at 4#{176}C (23) . The ability of the DMSO-methanol-EDTA to extract zinc mesoporphyrin quantitatively was also assessed. Zinc mesoporphyrin, final concentration 100 nmol/L, was added to the incubation buffer in the absence of substrates and incubated in the presence of lymphocyte protein for 60 mm. The mixture was extracted with DMSO-methanol-EDTA as described for the enzyme assay and the extract was subjected to HPLC separation. The mean analytical recovery of zinc mesoporphyrin with 60 pg of lymphocyte protein per tube was 98.6% (SD 1.4%, n = 12); with 105 pg of protein it was 98.8% (SD 1.0%, n = 10).
Optimum pH, time course, and linearity: Ferrochelatase activity was examined in buffers containing 150 mmol of Ti-is and 40 mmol of Bicine per liter, prepared at 22 #{176}C and covering a range from pH 7.4 to pH 9.0. Maximal activity was obtained at pH 8.0, which is similar to the pH 8.2 optimum reported for rat liver ferrochelatase (5, 11). The formation of zinc mesoporphyrin had a linear time course for at least 80 mm. We used a standard incubation time of 60 mm. Formation was also linear for lymphocyte total protein up to at least 100 pg per tube (Figure 3) . Camadro et al. (24) found that human liver contains large amounts of endogenous metal substrates (mainly zinc), which caused a lack of linearity of activity vs protein concentration. We did not observe this in our lymphocyte preparations, and incubation mixtures containing mesoporphyrin without added zinc did not form any zinc mesoporphyrin. Heat-inactivated lymphocyte preparations gave a non-enzymic product formation of 0.018 mmol . h' (Table 1 and Figure 3) , which was independent of the protein content up to at least 100 pg per tube.
Substrate kinetics: The ferrochelatase reaction follows a random bireactant mechanism in which each substrate binds randomly to the enzyme (24) . In such reactions, the apparent Michaelis constant (Km) for each substrate varies Several workers (14,26) have used total leukocyte fractions to measure ferrochelatase activity. Use of the lymphocyte fraction would have given a much higher activity. Ferrochelatase results obtained from total leukocyte fractions would be subject to variation within the same patient if the neutrophil count changed. On the other hand, any alteration in the lymphocyte count would be corrected by protein assay of each successive lymphocyte preparation. Fig.4 Erythrohepatic protoporphyria (EHP): We prepared lymphocyte sonicates using blood from three unrelated patients with EHP. The diagnosis of EHP was based on raised erythrocyte and plasma protoporphyrin.
HPLC fractionation (23) demonstrated that over 90% of the erythrocyte protoporphyrin was "free," i.e., not zinc chelated. As expected for EHP, the patients all had normal values for total porphyrins in urine. We tested the EHP lymphocyte preparations for endogenous protoporphyrin, which would have competed with the addedmesoporphyrin. These lymphocytes were deproteinized with DMSO-methanol-EDTA, and the supernates were injected into the HPLC. We used fluorescence settings specific for protoporphyrin (excitation wavelength 400 nm, emission wavelength 625 nm). The samples were also checked for endogenous zinc protoporphyrin (excitation 410 nm, emission 590 nm). Neither protoporphyrin nor its zinc chelate was detected. The EHP lymphocyte ferrochelatase activities were 1.11, 1.30,and 1.35 nmol h' mg', whereas the reference population range was 2.39-4.11 nmol-h1mg1 (mean ± 2 SD).
We conclude that this assay is simple in comparison with anaerobic incubations with 59Fe2 in the presence of reduc-ing agents. HPLC allows rapid separation and quantification of zinc mesoporphyrin, and fluorescence detection is sensitive enough to allow assay of ferrochelatase activity in lymphocytes from 5 to 10 mL of blood. The method could be applied to the study of disorders of heme biosynthesis such as sideroblastic anemia and lead poisoning, and is ideal for family studies in the inherited disease EHP.
